Mary Gleeson
Advanced in Primary Mediastinal B-Cell Lymphoma (PMBCL)

Mary Gleeson

Guy's And St Thomas' NHS Foundation Trust
London, ENG, GB 
Advanced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Guy's And St Thomas' NHS Foundation Trust
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Mary Gleeson practices in London, United Kingdom. Ms. Gleeson is rated as an Advanced expert by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her top areas of expertise are Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Primary Mediastinal B-Cell Lymphoma (PMBCL).

Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Primary Mediastinal B-Cell Lymphoma (PMBCL).

Gender
Female

Locations

Guy's and St Thomas' NHS Foundation Trust
London, ENG SE19RT, United Kingdom
Other Locations
Sutton Upon Derwent, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3

17 Total Publications

Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives.
Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives.
Journal: Cancers
Published: February 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gleeson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile